GDI2-IN-1
GDI2-IN-1 (compound (+) -37) is a GDP-dissociation inhibitor beta (GDI2) inhibitor with an IC50 of 2.87 μM and a KD of 36 μM. GDI2-IN-1 exhibits excellent in vivo antitumor activity in GDI2-overexpressing pancreatic xenograft models[1].
Product Specifications
UNSPSC
12352005
Target
ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gdi2-in-1.html
Solubility
10 mM in DMSO
Smiles
O[C@](C[C@@H]1C)(CC2=CN(CC3=CC=C(F)C=C3)N=N2)C[C@@]4([H])N1CCC5=C4C=C(OCC6=CC(C)=CC(C)=C6)C(OCC7=CC(C)=CC(C)=C7)=C5
Molecular Formula
C42H47FN4O3
Molecular Weight
674.85
References & Citations
[1]Yong Sun, et al. Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[a]quinolizidine Library to Induce Paraptosis for Cancer Therapy. JACS Au 2023, September 26, 2023.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682094-500 1x 500 µL
P53 Tumor Suppressor Protein (rBP53-12), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682622-100 1x 100 µL
MSH2 (DNA Mismatch Repair Marker) (MSH2/2622), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details